Letter to the Editor
An aggressive case of Fluid overload–associated large B-cell lymphoma (FO-LBCL) with CD20 down-regulation
キーワード:
fluid overload–associated large B-cell lymphoma (FO-LBCL),
CD20 negative,
polatuzumab vedotin,
rituximab
2025 年 65 巻 1 号 p. 77-80
詳細
記事の1ページ目
